Back row (L to R):
Victor Amador, Christopher Surdock, David Sobczak, Elizabeth Butch
Front row (L to R):
Tracy McGraw, Mario Otto, Scott Snyder, Amy Vavere, Zapporah Young
Molecular Imaging Research is comprised of two distinct, yet synergistic, components – Clinical and Research. Our work centers on the use of positron-emitting radionuclides to detect and monitor cancers and other diseases through the use of Positron Emission Tomography (PET). The cyclotron facility was built as a part of the new Chili's Care Center and began production of radionuclides in February of 2008. Shortly after, we began the full, in-house production of [18F]2-fluoro-2-deoxy-D-glucose (18F-FDG) for routine, clinical use by Nuclear Medicine. In addition, we are providing [11C]Methionine for a research protocol imaging solid tumors, with many other radiotracers in development.
Along with providing clinical support for the Nuclear Medicine department, we are involved in many basic research projects. As members of both Radiological Sciences and Chemical Biology & Therapeutics, our lab has a wealth of resources at our disposal. Through collaborative efforts with researchers on and off campus, we use radionuclidic labeling to determine the fate of drug candidates in biological systems. We are also working on specific PET imaging agents to follow biochemical processes in real time.
View the Cyclotron Video.